Review
Open access
Oct 2026
Expanding Patient Access to Innovative Drugs in Canada
Canada has an opportunity to learn from best practices in other jurisdictions to streamline reimbursement pathways and provide earlier, equitable access to new therapies for a greater number of patients, including specific access challenges associated with new dermatological treatments.
Maxwell Sauder, M. Ponzo
· Canadian Dermatology Today · 0 citations